Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China
· Delayed Price · Currency is CNY 14.00
+1.02 (7.86%)
Mar 10, 2026, 2:45 PM CST
SHE:300246 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,396 | 1,724 | 2,725 | 2,869 | 3,192 | 3,795 | Upgrade
|
| Market Cap Growth | 88.12% | -36.74% | -5.01% | -10.13% | -15.90% | 67.83% | Upgrade
|
| Enterprise Value | 3,507 | 2,011 | 2,906 | 2,602 | 3,246 | 3,552 | Upgrade
|
| Last Close Price | 12.98 | 6.55 | 10.24 | 10.69 | 14.14 | 16.46 | Upgrade
|
| PE Ratio | - | - | - | 129.62 | 50.04 | 10.97 | Upgrade
|
| Forward PE | - | 61.78 | 61.78 | 61.78 | 61.78 | 61.78 | Upgrade
|
| PS Ratio | 3.25 | 1.63 | 2.28 | 2.42 | 2.93 | 2.72 | Upgrade
|
| PB Ratio | 2.64 | 1.34 | 1.96 | 1.91 | 3.22 | 3.68 | Upgrade
|
| P/TBV Ratio | 3.15 | 1.58 | 2.33 | 2.40 | 4.72 | 5.49 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 9.80 | Upgrade
|
| P/OCF Ratio | 49.46 | - | 21.12 | 20.39 | 39.60 | 8.33 | Upgrade
|
| EV/Sales Ratio | 3.35 | 1.90 | 2.43 | 2.20 | 2.98 | 2.54 | Upgrade
|
| EV/EBITDA Ratio | - | - | 33.12 | 69.06 | 29.86 | 7.97 | Upgrade
|
| EV/EBIT Ratio | - | - | 77.76 | - | 44.71 | 8.30 | Upgrade
|
| EV/FCF Ratio | -39.62 | - | - | - | - | 9.17 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.50 | 0.42 | 0.28 | 0.36 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 144.40 | 647.00 | 6.13 | 9.59 | 3.15 | 0.60 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.69 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | -0.07 | -0.17 | -0.23 | 0.02 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.30 | 10.90 | -2.69 | -9.35 | 0.18 | -0.48 | Upgrade
|
| Net Debt / FCF Ratio | -0.41 | 0.75 | 2.59 | 4.96 | -0.24 | -0.56 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.48 | 0.57 | 0.66 | 1.09 | Upgrade
|
| Inventory Turnover | 3.09 | 3.46 | 3.87 | 4.21 | 4.30 | 6.47 | Upgrade
|
| Quick Ratio | 1.20 | 1.55 | 1.44 | 1.83 | 1.20 | 1.75 | Upgrade
|
| Current Ratio | 1.62 | 1.97 | 1.78 | 2.21 | 1.67 | 2.20 | Upgrade
|
| Return on Equity (ROE) | -4.76% | -5.23% | -4.22% | 1.97% | 6.64% | 43.53% | Upgrade
|
| Return on Assets (ROA) | -1.69% | -1.64% | 0.94% | -0.20% | 2.73% | 20.82% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.08% | -5.58% | 3.25% | -0.61% | 6.85% | 51.56% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.90% | -3.60% | 2.10% | -0.40% | 5.90% | 35.30% | Upgrade
|
| Earnings Yield | -1.95% | -4.14% | -2.39% | 0.77% | 2.00% | 9.12% | Upgrade
|
| FCF Yield | -2.61% | -6.52% | -3.35% | -2.48% | -2.59% | 10.21% | Upgrade
|
| Dividend Yield | 0.77% | - | - | 1.25% | 0.94% | 1.62% | Upgrade
|
| Payout Ratio | - | - | - | 184.49% | 91.47% | 9.58% | Upgrade
|
| Buyback Yield / Dilution | -1.95% | 0.51% | -1.23% | -18.96% | 0.26% | -0.26% | Upgrade
|
| Total Shareholder Return | -1.18% | 0.51% | -1.23% | -17.71% | 1.20% | 1.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.